Press

• The Regional Minister for Economic and Business Development, Mikel Irujo, underlines Navarre's leadership and highlights the importance of BIOSPAIN in promoting relations between Navarrese companies and those from other regions and also at a global level.
• The international congress concludes with nearly a thousand professionals from 600 organisations from 30 countries and more than 2,000 'one-to-one' meetings.

• The President of Navarra, María Chivite, has described this sector as strategic for economic recovery and with great potential for job creation.
• This international benchmark event, organised by AseBio, in coordination with the Government of Navarra, has more than 900 attendees from 30 countries and more than 2,000 one-to-one meetings have already been held.

Biotech companies launched 70% more products and services to market and Spain moved to eighth in the world in scientific production in biotechnology

• The pandemic has provided an opportunity for Spanish biotechnology and private investment has increased by 50% in 2020. 
• BIOSPAIN 2021, the reference Spanish trade fair for investment agents and biotech companies, will take place from 27 September to 1 October

Biotech companies are expanding their workforce amid the pandemic, accentuating in 2020 the growth trend of recent years, in which staff increased by 7.6% in 2019 and accounted for 12.8% of people working in R&D in Spain as a whole. 

This year saw over €150 million in private capital invested, compared to €103 million in 2019. Publicly traded biotech firms attracted over €70 million on capital markets, up 35% from 2019

Spain is positioned as a leader and benchmark country in advanced therapies, the cornerstone for the treatment of diseases such as cancer, where 62% of clinical trials are conducted.